Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Oblato, Inc.

By efain on Tue, 04/06/2021 - 17:05
  • Read more about Oblato, Inc.

Pharvaris

By efain on Fri, 03/12/2021 - 13:49
  • Read more about Pharvaris

Exelixis, Inc.

By efain on Fri, 03/05/2021 - 12:53
  • Read more about Exelixis, Inc.

Taiho Oncology, Inc

By efain on Thu, 02/25/2021 - 11:45
  • Read more about Taiho Oncology, Inc

1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide.

  • Read more about 1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide.

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

  • Read more about Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19

  • Read more about A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

  • Read more about MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumor

  • Read more about Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumor

Corticosteroids in Severe COVID-19(ASAP-C Study)

  • Read more about Corticosteroids in Severe COVID-19(ASAP-C Study)

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • Current page 174
  • Page 175
  • Page 176
  • Page 177
  • Page 178
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA